Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
US Department of Justice
Cipla
UBS
Fish and Richardson
Boehringer Ingelheim
Cantor Fitzgerald
Argus Health
Accenture
Baxter

Generated: February 24, 2018

DrugPatentWatch Database Preview

DAPTOMYCIN Drug Profile

« Back to Dashboard

When do Daptomycin patents expire, and what generic alternatives are available?

Daptomycin is a drug marketed by Crane Pharms Llc, Hospira Inc, Teva Parenteral, Sagent Pharms, and Xellia Pharms Aps. and is included in five NDAs.

The generic ingredient in DAPTOMYCIN is daptomycin. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the daptomycin profile page.
Drug patent expirations by year for DAPTOMYCIN
Pharmacology for DAPTOMYCIN
Ingredient-typeLipopeptides
Drug ClassLipopeptide Antibacterial
Medical Subject Heading (MeSH) Categories for DAPTOMYCIN

US Patents and Regulatory Information for DAPTOMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Crane Pharms Llc DAPTOMYCIN daptomycin POWDER;INTRAVENOUS 206005-001 Jun 15, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sagent Pharms DAPTOMYCIN daptomycin POWDER;IV (INFUSION) 208385-001 Sep 12, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc DAPTOMYCIN daptomycin POWDER;INTRAVENOUS 202857-001 Sep 12, 2014 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Parenteral DAPTOMYCIN daptomycin POWDER;INTRAVENOUS 091039-001 Mar 25, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Xellia Pharms Aps DAPTOMYCIN daptomycin POWDER;IV (INFUSION) 209949-001 Oct 20, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
UBS
Colorcon
QuintilesIMS
Citi
Chinese Patent Office
Healthtrust
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot